RxDoctor Payments Data

Laurence Gordon, DO

Internal Medicine · Chicago, ILNPI 1942220900

Payments from drug & device makers

$7,246in general payments, 2019–2025

Across 158 payments — averaging $45.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • GSK$2K
  • AstraZeneca$620
  • Boehringer Ingelheim$521
  • Novo Nordisk$379
  • Pfizer$186
  • plus $1K from 17 others

What the payments were for

  • Consulting fees$1,82525%
  • Speaking & faculty fees$2,55035%
  • Food & beverage$2,85439%
  • Education$170%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,246 in reported general payments places this provider in the 90th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$12,254
Medicare patients
104
Services billed
274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin27$31,705
EliquisApixaban26$29,745
XareltoRivaroxaban24$27,547
OzempicSemaglutide11$17,762
Esomeprazole Magnesium15$2,741
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,501
Celecoxib27$1,770
Atorvastatin Calcium282$1,666
SynthroidLevothyroxine Sodium14$1,627
Omeprazole144$1,531
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$971
Levothyroxine Sodium84$889
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$807
Irbesartan65$770
Metoprolol Succinate50$763

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$521$31,70527 claims
PfizerEliquis$186$29,74526 claims
Johnson & JohnsonXarelto$61$27,54724 claims
Novo NordiskOzempic$379$17,76211 claims
AbbVieSynthroid$2,694$1,62714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →